Abstract
The recent outbreak of COVID-19 has brought elective surgeries including liver transplantation to a standstill. The concerns in Living Donor Liver Transplant (LDLT) were that immunosuppressed recipients and healthy donors would be exposed to nosocomial SARS- CoV-2 infection.1 However, as patients began to suffer and die, Liver Transplant Society of India (LTSI) revised its guidelines 2 and allowed LDLT for those who were very sick, or had just recovered from a life threatening decompensation (high MELD/ CTP score) or had malignancy. Over 90 % of transplants in India are from live donors as we have a very low donation rate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
